Geneva, July 7 -- International Clinical Trials Registry received information related to the study (KCT0012186) titled 'Human clinical Trial for the efficacy of AUL NiacinGold™ Sun Screen in improving the skin barrier damaged by ultraviolet (UV) rays and redness damaged by UV rays after one use' on June 26.
Study Type: Interventional Study
Study Design:
Primary Purpose : Prevention, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : Not Applicable
Primary Sponsor: Human Co., Ltd. Skin Clinical Trial Center
Condition:
Factors influencing health status and contact with health services
Intervention:
Others(A (AUL NiacinGold Sun Screen) and B (non-treated control site) comparison) : In this study, each subject...